Aug 4, 2026 06:45AM
Jul 30, 2026 06:45AM
Jul 30, 2026 06:45AM
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 10, 2026 11:23AM
Jul 10, 2026 11:23AM U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
Jun 24, 2026 02:10PM
Jun 24, 2026 02:10PM
Jun 24, 2026 11:42AM
Jun 24, 2026 08:30AM
Jun 23, 2026 12:15PM
Jun 9, 2026 09:44AM
Jun 8, 2026 06:45AM FDA approves expanded HYMPAVZI use for hemophilia patients with inhibitors
Jun 8, 2026 06:45AM
Jun 1, 2026 02:54AM
Jun 1, 2026 02:53AM
May 31, 2026 08:00AM
May 30, 2026 08:00AM
May 29, 2026 12:07PM
May 29, 2026 08:02AM Pfizer's LORBRENA shows 55% seven-year survival without progression
May 29, 2026 08:00AM
May 18, 2026 08:00AM
May 13, 2026 06:45AM
May 13, 2026 06:45AM
May 12, 2026 12:53PM
May 12, 2026 09:00AM
May 12, 2026 07:01AM Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront
May 12, 2026 07:00AM
May 12, 2026 07:00AM
May 11, 2026 08:30AM
May 5, 2026 06:45AM
May 1, 2026 12:43PM
Apr 29, 2026 06:45AM
Apr 29, 2026 06:45AM Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
Apr 21, 2026 11:51AM
Apr 20, 2026 06:45AM
Apr 20, 2026 06:45AM
Apr 7, 2026 08:30AM
Apr 7, 2026 08:30AM
Apr 1, 2026 12:16PM
Mar 19, 2026 06:45AM Pfizer's TALZENNA combination shows progress against prostate cancer
Mar 19, 2026 06:45AM
Mar 9, 2026 10:53AM
Feb 27, 2026 10:04AM
Feb 27, 2026 10:00AM
Feb 24, 2026 02:30PM
Feb 24, 2026 02:29PM
Feb 19, 2026 05:31PM Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Feb 17, 2026 05:31PM

328,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All